English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduLeaders of organizations that fund vision research convene in Washington, D.C. to increase collaboration and maximize the impact of research funding for sight-threatening diseases.
Tag: Vision
Inflammation-reducing drug shows no benefit for dry age-related macular degeneration in NIH trial
The drug minocycline, an antibiotic that also decreases inflammation, failed to slow vision loss or expansion of geographic atrophy in people with dry age-related macular degeneration (AMD), according to a phase II clinical study at the National Eye Institute (NEI),…
Upcoming Solar Eclipse—Mount Sinai Ophthalmologists Warn About Dangers of Looking Directly at the Sun
Warning follows Mount Sinai’s landmark eye damage case linked to the 2017 eclipse
The influence of the cellular environment on vision
The research team investigated the four extracellular matrix proteins Brevican, Neurocan, Tenascin-C and Tenascin-R, which occur in the cell environment of nerve cells of the retina.
How Much Vision Loss is Too Much When it Comes to Driving?
When’s the right time for an older adult to stop driving? Researchers at the University of Western Australia sought to shed light on this question by investigating at what point declining vision increases the risk of a car accident.
World’s Largest Meeting of Eye Physicians and Surgeons Spotlights Advances in Artificial Intelligence
AAO 2023 delivers opportunities to hear from the greatest minds in medical and surgical eye care discuss the latest scientific breakthroughs in vision treatment and research.
Doctor Shares Benefits Of Cataract Surgery
David Winter, MD, at Baylor Scott & White Health, answers the most common patient questions and reacts to the latest medical research. Winter, you recently had cataract surgery. How are you doing, and has your vision improved? (SOT@ :14, TRT…
New strategy for eye condition could replace injections with eyedrops
A new compound developed at the University of Illinois Chicago potentially could offer an alternative to injections for the millions of people who suffer from an eye condition that causes blindness
Older people may have glaucoma without realizing it
It can be hard to know that you have glaucoma. In a study carried out at the University of Gothenburg, almost five percent of 70-year-olds were found to have glaucoma, and half of those diagnosed were unaware that they had the disease.
“Eggsplosions” and eyes don’t mix
Microwaving hard-boiled eggs is one of the latest TikTok trends that can harm your eyes
Research to Prevent Blindness and Association of University Professors of Ophthalmology Announce 2024 Recipient of RPB David F. Weeks Award for Outstanding Vision Research
Patricia Ann D’Amore, PhD, MBA, has been selected as the 2024 RPB David F. Weeks Award for Outstanding Vision Research (Weeks Award). Dr. D’Amore will receive her award and deliver a presentation during the AUPO 2024 Annual Meeting in Austin, Texas in February.
The Medical Minute: Early detection key to protecting vision from glaucoma
Glaucoma can develop for years before you experience a symptom. A Penn State Health optometrist discusses early diagnosis and how testing can make all the difference for your vision.
Eye drops slow nearsightedness progression in kids, study finds
The results of a new clinical trial suggest that the first drug therapy to slow the progression of nearsightedness in kids could be on the horizon.
NEI Scientists publish recipe for making blood vessel cells from patient stem cells
Researchers at NIH’s National Eye Institute have published a detailed protocol for making three cell types that are key components to form blood vessels and capillaries.
Research to Prevent Blindness Announces New Sight-Saving Vision Research Grants
Research to Prevent Blindness (RPB) announces two new grants to support high-impact vision research. The new grants are the: RPB / Tom Wertheimer Career Development Award in Data Science and RPB / Mary Tyler Moore Vision Initiative Physician-Scientist Award.
Eye-opening Origin Story: Scientists Trace Key Innovation in Our Camera-like Vision to Bacteria
Scientists have traced the origin of a unique protein key to vertebrate’s camera-like vision back 500 million years. Their analysis of more than 900 genomes across the tree of life revealed that the protein came through horizontal gene transfer from foreign bacterial genes.
Study Shows Primary Visual Cortex in Mice Is Highly Sensitive to UV-Green Color Contrast
Article title: Joint representations of color and form in mouse visual cortex described by random pooling from rods and cones Authors: Issac Rhim and Ian Nauhaus From the authors: “This study is the first to show that mouse [primary visual…
New form of omega-3 could prevent visual decline with Alzheimer’s disease
For the first time, researchers have developed a form of the omega-3 fatty acid docosahexaenoic acid (DHA) that is capable of crossing into the eye’s retina to ward off visual declines related to Alzheimer’s disease, diabetes and other disorders.
Vision Research Funding Partnership Event Takes Place Today
Today, Research to Prevent Blindness (RPB) and more than 30 other organizations are convening in Washington DC for the Vision Research Funding Partnership event, which was organized around the theme of “The Research Pipeline – From Premise to Patient.”
Cataract surgery reimbursements may not be enough for some patients
Research suggests that Medicare reimbursements for complex cataract surgery cover less than two minutes of operating time, and an increase to reimbursements for the procedure may be justified. Complex cataract surgery requires more time and resources than simple cataract surgery, and this study indicates that the incremental reimbursement for the complex surgery is not enough to offset the increased costs.
新的基因编辑技术成功地逆转小鼠的视力损失
视网膜色素变性症是人类失明的主要原因之一。中国的研究人员成功地恢复了患有视网膜色素变性症的小鼠的视力。该研究将于[三月十七日]发表在《实验医学杂志》上。该研究使用一种新型的、高度通用的CRISPR基因组编辑技术，有潜力纠正各种导致疾病的遗传突变。
New gene-editing technique reverses vision loss in mice
Researchers in China have successfully restored the vision of mice with retinitis pigmentosa, one of the major causes of blindness in humans. The study, to be published March 17 in the Journal of Experimental Medicine, uses a new, highly versatile form of CRISPR-based genome editing with the potential to correct a wide variety of disease-causing genetic mutations.
Beezin’: The dangerous TikTok trend involving Burt’s Bees
Why putting lip balm on eyelids is bad for your eyes
UT Southwestern ophthalmologist shares techniques for cataract surgery complications
Patients undergoing cataract surgery typically have their natural lens replaced with an artificial intraocular lens (IOL). But complications occasionally arise that require the placement of a more surgically challenging secondary IOL. Several techniques are available for secondary IOL placement, and each has its advantages and disadvantages.
Many older adults lack clear eyesight, even with glasses
Vision impairment disproportionately impacts older adults
Zebrafish model helps explain eye development
Scientists at the National Eye Institute (NEI) have developed a zebrafish model of NEDBEH—a rare genetic disorder that can cause coloboma, where parts of the eye are missing due to developmental defects. The model provides a new tool for understanding the eye’s embryonic development. The NEI is part of the National Institutes of Health.
Research to Prevent Blindness Marks $400 Million in Funding to Advance Eye Disease Research
Research to Prevent Blindness announces a new round of awardees who are generating critical knowledge around a host of sight-threatening conditions. With this latest round of funding, RPB has provided more than $400 million in research funding.
UC Davis Health opens doors to new state-of-the-art eye care facility in Sacramento
UC Davis Health welcomed the first patients to the new Ernest E. Tschannen Eye Institute on Monday, Dec. 5. The state-of-the-art facility, which houses both clinicians and researchers, is dedicated to advancing world-class eye care and offering hope for sight restoration.
Eye-opening discovery about adult brain’s ability to recover vision
A discovery about how some visually impaired adults could start to see offers a new vision of the brain’s possibilities. The finding that the adult brain has the potential to partially recover from inherited blindness comes from a collaboration between researchers in the University of California, Irvine School of Biological Sciences and the School of Medicine.
Research to Prevent Blindness and Association of University Professors of Ophthalmology Announce 2023 Recipient of RPB David F. Weeks Award for Outstanding Vision Research
David J. Calkins, PhD, has been selected as the 2023 RPB David F. Weeks Award for Outstanding Vision Research.
The Medical Minute: How parents can prioritize their child’s eye health
When is the best time to take your child to see the eye doctor? How can you protect their vision during their formative years? A Penn State Health ophthalmologist dots the Is for you.
Research to Prevent Blindness and the American Academy of Ophthalmology Award New Research Grants to Improve Eye Care
Award recipients to use the American Academy of Ophthalmology IRIS® Registry (Intelligent Research in Sight) clinical database to improve care for all patients
“Brain bleeds” in babies first year can lead to long-term sight problems, study finds
Severe “brain bleeds” experienced by some babies in the first year following their birth lead to long-term sight problems, researchers at the University of Bristol have found as part of a ten-year follow-up study.
The limits of vision: seeing shadows in the dark
A dedicated neural circuit in the retina detects shadows even in near-complete darkness
Study Finds Why Baby Leatherback Marine Turtles Can’t ‘See the Sea’
For most sea turtles, the journey to find the ocean from their nests is pretty straightforward. However, leatherback hatchlings more often crawl around in circles trying to find the ocean. Circling delays their entry into the ocean, wastes energy, and places them at greater danger from natural predators. Under different moon phases: bright light during full moon and only starlight under new moon, researchers have a better understanding of why this circling behavior happens and why it is most commonly observed in leatherbacks.
National Academy of Sciences names two UCI faculty members as fellows
Irvine, Calif., May 4, 2022 – Two University of California, Irvine researchers have been elected to the National Academy of Sciences, one of the world’s most respected scientific organizations. Svetlana Jitomirskaya, Distinguished Professor of mathematics, and Krzysztof Palczewski, Distinguished Professor of ophthalmology, are among 120 U.
ARVO Women’s Leadership Development Program welcomes Class of 2021
The Association for Research in Vision and Ophthalmology (ARVO) today recognized the 2021 class of its popular Women’s Leadership Development Program (WLDP).
Research to Prevent Blindness and Association of University Professors of Ophthalmology Announce 2022 Recipient of RPB David F. Weeks Award for Outstanding Vision Research
Donald Zack, MD, PhD, is recognized for ground-breaking contributions to the field of vision research, funded by Research to Prevent Blindness, an anonymous donor, and the Association of University Professors of Ophthalmology.
Dry Eye Awareness Month 2021 Focuses on a Looming Lifestyle Epidemic—Ocular Surface Disease
The vision community and its coalition partners announce awareness and educational activities in July 2021 around the annual recognition of Dry Eye Awareness Month.
Research suggests fly brains make predictions — possibly by using universal design principles
New research in flies indicates that prediction may be a universal principle among animal nervous systems to enable rapid behavioral changes.
ARVO elects new Editors-in-Chief for its three journals
The Association for Research in Vision and Ophthalmology (ARVO) has announced the election of new Editors-in-Chief (EICs) for its three open-access journals — Investigative Ophthalmology & Visual Science (IOVS), Journal of Vision (JOV) and Translational Vision Science & Technology (TVST).
ARVO Foundation Announces Winner of Ludwig von Sallmann Clinician-Scientist Award
The Association for Research in Vision and Ophthalmology (ARVO) today announced the recipient of the Ludwig von Sallmann Clinician-Scientist Award. The award, which recognizes Ludwig von Sallmann, MD, honors awardees with a $1,250 honorarium, an inscribed award and invitations to several special events at the ARVO Annual Meeting. The 2021 recipient of the award is Sai Chavala, MD, of Texas Christian University (TCU) and The University of Northern Texas Health Science Center (UNTHSC) School of Medicine in Fort Worth, Texas.
ARVO Foundation Announces Winner of Oberdorfer Award in Low Vision Research
The Association for Research in Vision and Ophthalmology (ARVO) today announced the recipient of the Oberdorfer Award in Low Vision Research. The award, which honors Michael D. Oberdorfer, PhD, recognizes a recipient with a $1,250 honorarium, an inscribed award and invitations to several special events at the ARVO Annual Meeting. The 2021 recipient of the award is Caroline Klaver, MD, PhD of Erasmus Medical Center, Radboud University Medical Center, and the Institute of Molecular and Clinical Ophthalmology Basel (IOB).
Audacious projects develop imaging technology to aid eye tissue regeneration
As regenerative therapies for blinding diseases move closer to clinical trials, the National Eye Institute’s functional imaging consortium, a part of the NEI Audacious Goals Initiative (AGI), is pioneering noninvasive technologies to monitor the function of the retina’s light-sensing neurons and their connections to the brain.
A Single Injection Reverses Blindness in Patient with Rare Genetic Disorder
A Penn Medicine patient with a genetic form of childhood blindness gained vision, which lasted more than a year, after receiving a single injection of an experimental RNA therapy into the eye.
Gene Therapy Shows Promise in Initial Trial for Patients with Childhood Blindness
A new gene therapy for one of the most common forms of congenital blindness was safe and improved patients’ vision, according to initial data from a clinical trial.
New Fellowships Support Under-Represented Minorities in Glaucoma Research
The Glaucoma Foundation (TGF) and Research to Prevent Blindness (RPB) have partnered to launch a new grant aimed at supporting under-represented racial and ethnic minority researchers in the pursuit of glaucoma research. The TGF (sponsored by Patricia Hill) / RPB Fellowships in Glaucoma provide one-year, $10,000 fellowships focused on substantive glaucoma research.
Vision Impairment is Associated with Mortality
A meta-analysis finds that vision impairment and blindness are tied to an increased risk of mortality, prompting the need to address global eye health disparities.
Neutrons probe molecular behavior of proposed COVID-19 drug candidates
Using neutron experiments and computer simulations, researchers from Oak Ridge National Laboratory delved into how some of the proposed COVID-19 drug candidates behave at the molecular scale when exposed to water.
ARVO Foundation Announces 2021 Pfizer Ophthalmics Carl Camras Translational Research Award Recipient
The Association for Research in Vision and Ophthalmology (ARVO) today announced the recipient of the Pfizer Ophthalmics Carl Camras Translational Research Award. The award, funded by Pfizer Ophthalmics through the ARVO Foundation, honors Dr. Carl Camras, who is highly respected for his work as a glaucoma specialist and a research scientist, by annually awarding up to three $12,000 awards to young investigators working in areas of translational research. The 2021 awardee is Alex Huang, MD, PhD of the Doheny Eye Institute and University of California in Los Angeles.